Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Language
Publication year range
1.
J Hum Nutr Diet ; 32(6): 810-818, 2019 12.
Article in English | MEDLINE | ID: mdl-31305957

ABSTRACT

BACKGROUND: Menopause has been associated with an increased risk of cardiovascular disease. It has been shown that isoflavones protect vascular endothelial cells against induced oxidative stress injury. Therefore, the present study aimed to investigate the association between the dietary intake of isoflavones and the presence of subclinical cardiovascular disease (CVD) in postmenopausal women. METHODS: Ninety-six postmenopausal women [mean (SD) age 55.2 (4.9) years, body mass index (BMI) 27.2 (4.6) kg m-2 ] completed the study protocol. Habitual physical activity was assessed using a digital pedometer, resting metabolic rate was measured by indirect calorimetry and dietary intake was assessed via a validated food frequency questionnaire. Subclinical CVD was defined as carotid artery intima-media thickness (C-IMT) >0.9 mm and/or the presence of one or more atherosclerotic plaques in any of the studied segments. RESULTS: Mean (SD) C-IMT was 0.74 (0.2) mm, 25% of participants were found to have atherosclerotic plaques and the prevalence of subclinical CVD was 35%. Participants with subclinical CVD were more likely to consume less selenium, magnesium, folate and isoflavones, even after adjusting for total energy intake. A multivariate-adjusted regression model showed that a BMI >27 kg m-2 was associated with 90% higher risk of having ≥1 plaque and/or C-IMT >0.9 mm (P = 0.017). Higher oestradiol levels (P = 0.004) and isoflavone intake (P = 0.021) were independently associated with a lower risk of having subclinical CVD. CONCLUSIONS: In the present study, we observed that a higher isoflavone dietary intake was associated with a lower risk of subclinical CVD in postmenopausal women, independent of BMI and endogenous oestradiol levels.


Subject(s)
Cardiovascular Diseases/epidemiology , Diet , Isoflavones/administration & dosage , Postmenopause , Body Mass Index , Cardiovascular Diseases/pathology , Carotid Intima-Media Thickness , Cross-Sectional Studies , Estradiol/blood , Exercise , Female , Humans , Middle Aged , Overweight/epidemiology , Plaque, Atherosclerotic/pathology , Risk Factors
2.
Climacteric ; 16(5): 576-83, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23234242

ABSTRACT

OBJECTIVE: To investigate the impact of waist circumference (WC) on heart rate variability in 87 apparently healthy, postmenopausal women. METHODS: In this cross-sectional study, time- and frequency-domain heart rate variability indices were determined at rest and during sympathetic stimulation with mental stress. Patients were stratified according to WC ≥ or < 88 cm. The mean (± standard deviation) age was 55 ± 5 years. The median time since menopause was 6 (range 1-22) years. Age and time since menopause were similar. RESULTS: The mean body mass index was 27.12 ± 4.49 kg/m². Metabolic syndrome was diagnosed in 26 (29.5%) participants. Thirty-eight participants (43.6%) had hypertension. Women with WC ≥ 88 cm had higher body mass index, glucose and insulin (both fasting and after a 75-g oral glucose tolerance test), HOMA, triglycerides, and free androgen index (p < 0.05). The metabolic syndrome was more frequent in women with WC ≥ 88 cm (24.13% vs. 5.74%; p < 0.01). At rest, women with WC ≥ 88 cm presented lower vagal modulation, expressed by a reduction in the mean of all normal RR intervals (mean RR) (p < 0.01) and root mean square of successive differences of adjacent RR intervals (rMSSD) (p < 0.05) than women with WC < 88 cm. Mental stress significantly increased sympathetic modulation in both groups, expressed by reduction in high frequency (HF), increase in low frequency (LF) and LF/F ratio, and reduction in mean RR and rMSSD. CONCLUSIONS: Less favorable metabolic profile and lower cardiac vagal modulation with preserved sympathetic responsiveness were found in participants with WC ≥ 88 cm, suggesting that central adiposity may be associated with decreased heart rate variability in apparently healthy, postmenopausal women.


Subject(s)
Abdominal Fat/physiopathology , Heart Rate/physiology , Obesity, Abdominal/physiopathology , Postmenopause/physiology , Blood Glucose/analysis , Body Mass Index , Cholesterol/blood , Cholesterol, HDL/blood , Cross-Sectional Studies , Female , Humans , Hypertension/diagnosis , Insulin/blood , Metabolic Syndrome/diagnosis , Metabolic Syndrome/physiopathology , Middle Aged , Risk Factors , Triglycerides/blood , Waist Circumference
3.
Braz. j. med. biol. res ; 44(1): 78-83, Jan. 2011. ilus, tab
Article in English | LILACS | ID: lil-571362

ABSTRACT

The aim of the present study was to assess the prevalence of osteoporosis in a sample of 32 patients with spontaneous primary ovarian insufficiency (POI) in comparison to reference groups of 25 pre- and 55 postmenopausal women. Hip (lumbar) and spinal bone mineral density (BMD) measurements were performed by dual-energy X-ray absorptiometry in the three groups. The median age of POI patients at the time of diagnosis was 35 years (interquartile range: 27-37 years). The mean ± SD age of postmenopausal reference women (52.16 ± 3.65 years) was higher than that of POI (46.28 ± 10.38 years) and premenopausal women (43.96 ± 7.08; P = 0.001) at the time of BMD measurement. Twenty-seven (84.4 percent) POI women were receiving hormone replacement therapy (HRT) at the time of the study. In the postmenopausal reference group, 30.4 percent were current users of HRT. Lumbar BMD was significantly lower in the POI group (1.050 ± 0.17 g/cm²) compared to the age-matched premenopausal reference group (1.136 ± 0.12 g/cm²; P = 0.040). Moreover, 22 (68.7 percent) POI women had low bone density (osteopenia/osteoporosis by World Health Organization criteria) versus 47.3 percent of the postmenopausal reference group (P = 0.042). In conclusion, the present data indicate that BMD is significantly lower in patients with POI than in age-matched premenopausal women. Also, the prevalence of osteopenia/osteoporosis is higher in POI women than in women after natural menopause. Early medical interventions are necessary to ensure that women with POI will maintain their bonemass.


Subject(s)
Adult , Female , Humans , Middle Aged , Osteoporosis/etiology , Primary Ovarian Insufficiency/complications , Absorptiometry, Photon , Bone Density , Hormone Replacement Therapy , Osteoporosis, Postmenopausal/diagnosis , Osteoporosis, Postmenopausal/etiology , Osteoporosis, Postmenopausal/physiopathology , Osteoporosis/diagnosis , Osteoporosis/physiopathology , Premenopause/physiology , Primary Ovarian Insufficiency/physiopathology
4.
Braz J Med Biol Res ; 44(1): 78-83, 2011 Jan.
Article in English | MEDLINE | ID: mdl-21085897

ABSTRACT

The aim of the present study was to assess the prevalence of osteoporosis in a sample of 32 patients with spontaneous primary ovarian insufficiency (POI) in comparison to reference groups of 25 pre- and 55 postmenopausal women. Hip (lumbar) and spinal bone mineral density (BMD) measurements were performed by dual-energy X-ray absorptiometry in the three groups. The median age of POI patients at the time of diagnosis was 35 years (interquartile range: 27-37 years). The mean ± SD age of postmenopausal reference women (52.16 ± 3.65 years) was higher than that of POI (46.28 ± 10.38 years) and premenopausal women (43.96 ± 7.08; P = 0.001) at the time of BMD measurement. Twenty-seven (84.4%) POI women were receiving hormone replacement therapy (HRT) at the time of the study. In the postmenopausal reference group, 30.4% were current users of HRT. Lumbar BMD was significantly lower in the POI group (1.050 ± 0.17 g/cm²) compared to the age-matched premenopausal reference group (1.136 ± 0.12 g/cm²; P = 0.040). Moreover, 22 (68.7%) POI women had low bone density (osteopenia/osteoporosis by World Health Organization criteria) versus 47.3% of the postmenopausal reference group (P = 0.042). In conclusion, the present data indicate that BMD is significantly lower in patients with POI than in age-matched premenopausal women. Also, the prevalence of osteopenia/osteoporosis is higher in POI women than in women after natural menopause. Early medical interventions are necessary to ensure that women with POI will maintain their bonemass.


Subject(s)
Osteoporosis/etiology , Primary Ovarian Insufficiency/complications , Absorptiometry, Photon , Adult , Bone Density , Female , Hormone Replacement Therapy , Humans , Middle Aged , Osteoporosis/diagnosis , Osteoporosis/physiopathology , Osteoporosis, Postmenopausal/diagnosis , Osteoporosis, Postmenopausal/etiology , Osteoporosis, Postmenopausal/physiopathology , Premenopause/physiology , Primary Ovarian Insufficiency/physiopathology
5.
J Endocrinol Invest ; 33(4): 239-43, 2010 Apr.
Article in English | MEDLINE | ID: mdl-19820294

ABSTRACT

BACKGROUND: Endothelial dysfunction is one of the early signs of cardiovascular damage. High androgen levels have been related to inflammatory endothelial markers in pre- and post-menopausal women. AIM: This cross-sectional study aimed at investigating whether free androgen index (FAI) [estimated by dividing total testosterone (nmol/l) by SHBG (nmol/l) x 100] is related to endothelial function during post-menopause. SUBJECTS AND METHODS: Twenty-six post-menopausal women were assessed with the dorsal hand vein compliance technique. Acetylcholine (Ach) and sodium nitroprusside (SNP) dose-response curves were constructed to test endothelium-dependent and independent relaxation, respectively. RESULTS: Mean age was 54 yr (+/-4) and median time since menopause was 6 yr (interquartile range: 3-9). Patients were stratified according to FAI levels into two groups: FAI greater than or less than the group median of 2.5. Waist-to-hip ratio (WHR) was significantly higher in the group with FAI>2.5, as well as median dose of Ach for maximal vasodilation [720 (360-3600) ng/min with FAI>2.5 vs 36 (0.36-360) ng/min with FAI

Subject(s)
Androgens/blood , Endothelium, Vascular/physiology , Postmenopause/physiology , Veins/anatomy & histology , Veins/physiology , Acetylcholine/pharmacology , Body Mass Index , Cross-Sectional Studies , Endothelium, Vascular/physiopathology , Female , Humans , Male , Middle Aged , Nitroprusside/pharmacology , Vasodilator Agents/pharmacology , Veins/drug effects , Waist-Hip Ratio
SELECTION OF CITATIONS
SEARCH DETAIL
...